Eye (London, England)۲۰۲۵مطالعه مشاهده ای۱۲ استنادنمایه شده در PubMed
Puja Maitra, Sujay Jaju, Kushal U Agrawal, Abhishek Das, Prema Subramaniam, Narendran Venkatapathy, Parag K Shah
چکیده
To compare the safety and efficacy of Bevacizumab, Ranibizumab and Ranibizumab biosimilar in treatment of Retinopathy of prematurity (ROP) METHODS: Retrospective study that included newborns with type 1 ROP who received intravitreal Bevacizumab (Avastin) or Ranibizumab (Accentrix) or Ranibizumab…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1038/s41433-025-03735-z